AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Carvitab 6.25 Tablet

Prescription Icon
Prescription Required

Marketer

ADN Life Sciences

Salt Composition

Carvedilol (6.25mg)

Overview Carvitab 6.25 Tablet

Cardiovasc 6.25mg tablets effectively manage hypertension, angina pectoris, and congestive heart failure. Its mechanism involves vasodilation, improving blood flow to the heart. This reduces blood pressure, mitigating the risk of future strokes and myocardial infarctions. Administer Cardiovasc 6.25mg with food, following your physician's prescribed dosage and regimen. Consistent use is crucial, even with symptom improvement or controlled blood pressure. Discontinuing treatment requires prior consultation to avoid potential complications. Lifestyle adjustments, including regular physical activity, weight management, smoking cessation, moderate alcohol consumption, and a low-sodium diet (as directed by your doctor), enhance treatment efficacy. While generally well-tolerated, potential side effects such as dizziness, headache, dyspnea, and fatigue may occur. Report any persistent or bothersome side effects to your doctor. Prior to commencing therapy, disclose any pre-existing cardiac or renal conditions. Pregnant or lactating individuals should seek medical advice before using Cardiovasc 6.25mg.

Uses of Carvitab 6.25 Tablet

Managing elevated blood pressure | Addressing angina pectoris | Treating congestive heart failure

Major Benefits of Carvitab 6.25 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Carvitab 6.25 Tablets should be administered with a meal.

Common Side effects of Carvitab 6.25 Tablet:

  • Decreased blood pressure
  • Headache
  • Fatigue
  • Dizziness
  • Breathlessness

How to use Carvitab 6.25 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Carvitab 6.25 Tablets should be administered with a meal.

How Carvitab 6.25 Tablet works:

Carvitab 6.25mg tablets combine alpha and beta-blocking actions. This dual mechanism reduces heart rate and dilates blood vessels, improving overall cardiac output.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Carvitab 6.25 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Carvitab 6.25 Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and Carvitab 6.25 mg tablets appear compatible. Available human data indicate minimal infant risk associated with this medication.

DrivingDrivingUNSAFE

Taking Carvitab 6.25 Tablet might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely use Carvitab 6.25 Tablets without altering the prescribed dosage. Nevertheless, disclosure of pre-existing kidney conditions to the physician is advised. Routine blood pressure monitoring is suggested to guide any necessary dosage modifications.

LiverLiverCAUTION

Patients with liver impairment should use Carvitab 6.25mg tablets cautiously, potentially requiring a modified dosage. Medical advice is recommended. Carvitab 6.25mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Carvitab 6.25 Tablet :

Should you forget a Carvitab 6.25 Tablet dose, take it immediately if you remember. However, near your next scheduled dose, omit the missed dose and resume your usual regimen. Never take a double dose.

Facts to Know About Carvitab 6.25 Tablet

LabelValue
Type of Compound Carbazole-based propanol compound
Addictive None.
Type of Medication HEART
Mechanism of Action Combined alpha and beta adrenergic receptor antagonist

FAQs on Carvitab 6.25 Tablet

Consistent use of Carvitab 6.25 mg tablets, as prescribed by your physician, is essential. Abrupt cessation may result in chest pain or myocardial infarction. If discontinuation is necessary, your doctor will gradually reduce your dosage to minimize risk.
Fatigue and dizziness are possible side effects of Carvitab 6.25 Tablet, particularly at treatment initiation or with dose escalation. Avoid driving or operating machinery if these symptoms arise.
Increased body weight is a frequently reported side effect associated with Carvitab 6.25 Tablet, though not universally experienced. Patients using Carvitab 6.25 Tablet to manage heart failure should promptly inform their physician of any weight increase or respiratory difficulties, as these could indicate fluid buildup.
In rare instances, administering Carvitab 6.25 mg tablets to individuals with heart failure might negatively impact kidney function. Nevertheless, the risk of kidney impairment is heightened in patients exhibiting hypotension (systolic blood pressure under 100 mmHg), atherosclerosis, pre-existing heart conditions, or compromised renal function. These patients require close observation while receiving Carvitab 6.25 mg tablets. Kidney function typically recovers once Carvitab 6.25 mg tablet administration ceases.
Diabetic patients may use Carvitab 6.25 Tablet, contingent upon consistent blood glucose monitoring. Studies in well-managed type 2 diabetes with mild to moderate hypertension indicate no impact on blood glucose levels. Nevertheless, beta-blockers, the drug class to which Carvitab 6.25 Tablet belongs, can mask hypoglycemic symptoms, particularly tachycardia. Furthermore, in diabetic patients with heart failure, Carvitab 6.25 Tablet might exacerbate hyperglycemia. Therefore, close blood glucose monitoring is crucial when starting, altering, or stopping Carvitab 6.25 Tablet. Report any blood glucose fluctuations during treatment to your physician.
Taking Carvitab 6.25 Tablet with food is advised. Food slows the medication's absorption, minimizing the risk of orthostatic hypotension—a drop in blood pressure leading to dizziness or fainting upon standing.
Taking Carvitab 6.25 mg tablets may lead to severe adverse reactions including dizziness, dyspnea, increased body weight, edema in the extremities, and thoracic discomfort. Other potential side effects are bradycardia or arrhythmia, skin eruptions (rash, urticaria, pruritus), and dysphagia. Seek immediate medical attention if any of these occur.
Exceeding the prescribed dosage of Carvitab 6.25 Tablet can lead to bradycardia, vertigo, syncope, respiratory distress, emesis, and potential loss of consciousness or convulsions. Consult your physician and obtain prompt medical attention at the nearest healthcare facility.
Patients with severe heart failure requiring intensive care unit hospitalization or circulatory support via intravenous inotropic medications should not use Carvitab 6.25 Tablet. Furthermore, this medication is contraindicated in individuals with asthma or respiratory conditions, bradycardia or arrhythmias, hepatic impairment, or known allergy to Carvitab 6.25 Tablet.
Carvitab 6.25 Tablet
53
MRP 65
18% off